Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-02-03

FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) manufactured by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLEGRA-D ALLERGY AND CONGESTION (Fexofenadine hydrochloride and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ALLEGRA-D ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)